Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03513536 · ClinicalTrials.gov registry record · NA
The Effect of Scent on Pregnancy Induced Nausea, Vomiting, and Quality of Life
A NA study, sponsored by Nutraceuticals Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT03513536: Completed NA study, sponsored by Nutraceuticals Research Institute.
NCT03513536 is a NA study that has completed, run by Nutraceuticals Research Institute. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03513536, a NA study, has completed, sponsored by Nutraceuticals Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
This study evaluates the effects of essential oils on nausea, vomiting, and quality of life scores among pregnant women. Participants will receive either an essential oil roll-on product or a placebo product to apply to their temples and jaw line daily for 6 days.
Primary Outcome
Nausea and vomiting are measured once per day using the 6-item Quantification of Emesis 24-hour scale (PUQE) scale. This scale includes 3 questions which are ranked on a scale of 1-5, with higher scores indicating higher levels of pregnancy-induced nausea and vomiting. The other 3 questions are open-ended questions which ask participants about perceived well-being.
Interventions
- OTHER Control
- OTHER Citrus-Based Aromatherapy
- OTHER Mint-Based Aromatherapy
- OTHER Spice-Scented Aromatherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2020-03-29 |
| Phase | NA |
What the finished NCT03513536 record still lists
NCT03513536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT03513536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03513536 about?
NCT03513536 is a clinical study titled "The Effect of Scent on Pregnancy Induced Nausea, Vomiting, and Quality of Life". This study evaluates the effects of essential oils on nausea, vomiting, and quality of life scores among pregnant women. Participants will receive either an essential oil roll-on product or a placebo product to apply to their temples and jaw line daily for 6 days.
What is the current status of trial NCT03513536?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2018-04-15. Estimated completion is 2020-03-29.
What interventions are being tested in trial NCT03513536?
The interventions under investigation include: Control (OTHER), Citrus-Based Aromatherapy (OTHER), Mint-Based Aromatherapy (OTHER), Spice-Scented Aromatherapy (OTHER).
Who is sponsoring clinical trial NCT03513536?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03513536's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI